Infectious aortitis

Current Treatment Options in Cardiovascular Medicine

Volumn 7, Issue 2, 2005, Pages 89-97

  Foote, Elizabeth A ^b   Postier, Russell G ^b   Greenfield, Ronald A ^b   Bronze, Michael S ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINOGLYCOSIDE; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIMETIDINE; CIPROFLOXACIN; CISPLATIN; CORTICOSTEROID; CYCLOSPORIN; DICLOXACILLIN; DIURETIC AGENT; FOSCARNET; LEVOFLOXACIN; NAFCILLIN; NEUROMUSCULAR BLOCKING AGENT; NITROFURANTOIN; NONSTEROID ANTIINFLAMMATORY AGENT; OXACILLIN; PROBENECID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; THEOPHYLLINE; UNINDEXED DRUG; VANCOMYCIN; WARFARIN;

ABDOMINAL AORTA; ABDOMINAL MASS; ABDOMINAL PAIN; AGE DISTRIBUTION; ANAPHYLAXIS; ANEURYSM RUPTURE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; AORTA ANEURYSM; AORTA GRAFT; AORTITIS; ATHEROSCLEROSIS; BACTERIAL ENDOCARDITIS; BACTERIAL INFECTION; BLEEDING; BLOOD CULTURE; BYPASS SURGERY; CHILL; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; CYTOPENIA; DEBRIDEMENT; DIARRHEA; DIZZINESS; DROWSINESS; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ERUPTION; DRUG EXCRETION; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG POTENTIATION; EMBOLISM; ENDOVASCULAR SURGERY; FEVER; FOLLOW UP; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HUMAN; INFECTION CONTROL; INJECTION PAIN; INSOMNIA; INTERSTITIAL NEPHRITIS; LEUKOCYTOSIS; MORTALITY; NAUSEA; NEPHROTOXICITY; NONHUMAN; OTOTOXICITY; PHLEBITIS; PSEUDOMEMBRANOUS COLITIS; RECURRENT INFECTION; REVASCULARIZATION; REVIEW; SALMONELLA; SEIZURE; SEPSIS; SERUM SICKNESS; SEX DIFFERENCE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PNEUMONIAE; TENDON RUPTURE; URTICARIA; VASA VASORUM; VOMITING;

EID: 27744550764     PISSN: 10928464     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11936-005-0010-6     Document Type: Review

References (38)

1. Bronze MS, Shirwany A, Corbett CE, Schaberg DR: Infectious aortitis: an uncommon manifestation of infection with Streptococcus pneumoniae. Am J Med 1999, 107:627-630.
2. Oz MC, Brener BJ, Buda JA, et al.: A ten-year experience with bacterial aortitis. J Vasc Surg 1989, 10:439-449.
3. Osler W: The Gulstonian Lectures on malignant endocarditis. BMJ 1885, 1:467-470.
4. Macedo TA, Stanson AW, Oderich GS, et al.: Infected aortic aneurysms: imaging findings. Radiology 2004, 231:250-257.
5. Berchtold C, Eibl C, Seelig MH, et al.: Endovascular treatment and complete regression of an infected abdominal aortic aneurysm. J Endovasc Ther 2002, 9:543-548.
6. Fillmore AJ, Valentine RJ: Surgical mortality in patients with infected aortic aneurysms. J Am Coll Surg 2003, 196:435-441.
7. Muller BT, Wegener OR, Grabitz K, et al.: Mycotic aneurysms of the thoracic and abdominal aorta and iliac arteries: experience with anatomic and extra-anatomic repair in 33 cases. J Vasc Surg 2001, 33:106-113.
8. Reddy DJ, Ernst CB: Infected aneurysms. In Vascular Surgery. Edited by Rutherford RB. Philadelphia: WB Saunders; 2000:1383-1397.
9. Oskoui R, Davis WA, Gomes MN: Salmonella aortitis. A report of a successfully treated case with a comprehensive review of the literature. Arch Intern Med 1993, 153:517-525.
10. Bayer AS, Scheld WM: Endocarditis and intravascular infections. In Principles and Practices of Infectious Diseases, edn 5. Edited by Mandell GL, et al. Philadelphia: Churchill Livingstone; 2000:857-902.
11. Guerrero F, Manuel L, Aguado JM, et al.: The spectrum of cardiovascular infections due to Salmonella enterica: a review of clinical features and factors determining outcome. Medicine (Baltimore) 2004, 83:123-128.
12. Soravia-Dunand VA, Loo VG, Salit IE: Aortitis due to Salmonella: report of 10 cases and comprehensive review of the literature. Clin Infect Dis 1999, 29:862-868.
13. Oz MC, McNicholas KW, Serra AJ, et al.: Review of Salmonella mycotic aneurysms of the thoracic aorta. J Cardiovasc Surg (Torino) 1989, 30:99-103.
14. Malouf JF, Chandrasekaran K, Orszulak TA: Mycotic aneurysms of the thoracic aorta: a diagnostic challenge. Am J Med 2003,115:489-496.
15. Ben-Haim S, Seabold JE, Hawes DR, Rooholamini SA: Leukocyte scintigraphy in the diagnosis of mycotic aneurysm. J Nucl Med 1992, 33:1486-1493.
16. Wein M, Bartel T, Kabatnik M, et al.: Rapid progression of bacterial aortitis to an ascending aortic mycotic aneurysm documented by transesophageal echocardiography. J Am Soc Echocardiogr 2001, 14:646-649.
17. Farkas JC, Fichelle JM, Laurian C, et al.: Long-term follow-up of positive cultures in 500 abdominal aortic aneurysms. Arch Surg 1993, 128:284-288.
18. van der Vliet JA, Kouwenberg PP, Muytjens HL, et al.: Relevance of bacterial cultures of abdominal aortic aneurysm contents. Surgery 1996, 119:129-132.
19. Vogt PR, Brunner-LaRocca HP, Lachat M, et al.: Technical details with the use of cryopreserved arterial allografts for aortic infection: influence on early and midterm mortality. J Vasc Surg 2002, 35:80-86.
20. Reddy DJ, Shepard AD, Evans JR, et al.: Management of infected aortoiliac aneurysms. Arch Surg 1991, 126:873-878; discussion 878-879.
21. Jarrett F, Darling C 3rd, Mundth ED, Austen WG: Experience with infected aneurysms of the abdominal aorta. Arch Surg 1975, 110:1281-1286.
22. Kryiakides C, Kan Y, Kerle M, et al.: 11-year experience with anatomical and extra-anatomical repair of mycotic aneurysms. Eur J Vasc Endovasc Surg 2004, 27:585-589.
23. Simon DR, Wishnow RM: An unusual presentation of salmonella aortitis. South Med J 1991, 84:657-659.
24. Gupta AK, Bandyk DF, Johnson BL: In situ repair of mycotic abdominal aortic aneurysms with rifampin-bonded gelatin-impregnated Dacron grafts: a preliminary case report. J Vasc Surg 1996, 24:472-476.
25. Deglin JH, Vallerand AH: Davis's Drug Guide, vol 6.0. Philadelphia: EA. Davis Co.; 2003.
26. Chambers HF: Sulfonamides, trimethoprim and quinolones. In Basic and Clinical Pharmacology, edn 8. Edited by Katzung BG. St. Louis: Lange Medical Books/McGraw-Hill; 2001:793-802.
27. Delgado RM, Munoz-Bellido JL, Ibanez PR, et al.: Antimicrobial resistance in non-typhi Salmonellae in Castilla y Leon. Res Esp Quimioter 2004, 17:29-36.
28. Gomes MN, Choyke PL, Wallace RB: Infected aortic aneurysms. A changing entity. Ann Surg 1992, 215:435-442.
29. Pagni S, Denatale RW, Sweeney T, et al.: Primary aortoduodenal fistula secondary to infected abdominal aortic aneurysms: the role of local debridement and extra-anatomic bypass. J Cardiovasc Surg (Torino) 1999, 40:31-35.
30. Hsu RB, Tsay YG, Wang SS, Chu SH: Surgical treatment for primary infected aneurysm of the descending thoracic aorta abdominal aorta, and iliac arteries. J Vasc Surg 2002, 36:746-750.
31. Luo CY, Ko WC, Kan CD, et al.: In situ reconstruction of septic aortic pseudoaneurysm due to Salmonella or Streptococcus microbial aortitis: long-term follow-up. J Vasc Surg 2003, 38:975-982.
32. Finseth FF, Abbott WM: One-stage operative therapy for Salmonella mycotic abdominal aortic aneurysm. Am Surg 1974, 179:8-11.
33. Cronenwett JL, Krupski WC, Rutherford RB: Abdominal aortic and iliac aneurysms. In Vascular Surgery, edn 5. Edited by Rutherford RB. Philadelphia: WB Saunders; 2000:1246-1280.
34. Flamand F, Harris KA, DeRose G, et al.: Arteritis due to Salmonella with aneurysm formation: two cases. Can J Surg 1992, 35:248-252.
35. Leseche G, Castier Y, Petit MD, et al.: Long-term results of cryopreserved arterial allograft reconstruction in infected prosthetic grafts and mycotic aneurysms of the abdominal aorta. J Vasc Surg 2001, 34:616-622.
36. Teebken OE, Pichlmaier MA, Brand S, Haverich A: Cryopreserved arterial allografts for in situ reconstruction of infected arterial vessels. Eur J Vasc Endovasc Surg 2004, 27:597-602.
37. Semba CP, Sakai T, Slonim SM, et al.: Mycotic aneurysms of the thoracic aorta: repair with use of endovascular stent-grafts. J vasc Interv Radiol 1998, 9(1 Pt 1):33-40.
38. Ishida M, Kato N, Hirano T, et al.: Limitations of endovascular treatment with stent-grafts for active mycotic thoracic aortic aneurysm. Cardiovasc Intervent Radiol 2002, 25:216-218.